 Marco De Dominici
Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 | 2023 | 256 | 1.490 |
Why?
| | Cyclin-Dependent Kinase 6 | 3 | 2021 | 37 | 1.450 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2022 | 26 | 0.800 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 3 | 2018 | 213 | 0.720 |
Why?
| | Skin | 2 | 2023 | 655 | 0.700 |
Why?
| | Skin Neoplasms | 2 | 2023 | 756 | 0.620 |
Why?
| | Recombinant Fusion Proteins | 1 | 2020 | 616 | 0.570 |
Why?
| | Protein Kinase Inhibitors | 3 | 2021 | 785 | 0.520 |
Why?
| | Genetic Predisposition to Disease | 1 | 2023 | 2086 | 0.490 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 4 | 2018 | 95 | 0.430 |
Why?
| | Hematopoietic Stem Cells | 3 | 2022 | 343 | 0.420 |
Why?
| | Clone Cells | 2 | 2023 | 247 | 0.390 |
Why?
| | Proto-Oncogene Proteins c-myb | 3 | 2021 | 9 | 0.360 |
Why?
| | Gene Expression Regulation, Leukemic | 3 | 2021 | 49 | 0.350 |
Why?
| | Neoplasms | 1 | 2021 | 2097 | 0.280 |
Why?
| | STAT5 Transcription Factor | 2 | 2018 | 44 | 0.280 |
Why?
| | Tumor Suppressor Proteins | 2 | 2018 | 282 | 0.240 |
Why?
| | Antineoplastic Agents | 3 | 2021 | 1879 | 0.210 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2020 | 698 | 0.200 |
Why?
| | MicroRNAs | 2 | 2018 | 600 | 0.200 |
Why?
| | DNA Modification Methylases | 1 | 2022 | 14 | 0.200 |
Why?
| | Lymphoma, B-Cell | 1 | 2023 | 86 | 0.200 |
Why?
| | Mice | 9 | 2021 | 14871 | 0.200 |
Why?
| | Cell Proliferation | 2 | 2020 | 2187 | 0.190 |
Why?
| | Molecular Targeted Therapy | 2 | 2021 | 347 | 0.190 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 2021 | 34 | 0.190 |
Why?
| | Chromatin | 2 | 2021 | 428 | 0.180 |
Why?
| | Cell Line, Tumor | 4 | 2020 | 2710 | 0.180 |
Why?
| | Genes, cdc | 1 | 2020 | 10 | 0.180 |
Why?
| | Interleukin-1beta | 1 | 2021 | 370 | 0.160 |
Why?
| | Molecular Structure | 1 | 2020 | 434 | 0.160 |
Why?
| | Blast Crisis | 1 | 2018 | 20 | 0.160 |
Why?
| | RNA, Neoplasm | 1 | 2018 | 80 | 0.150 |
Why?
| | Phosphorylation | 2 | 2020 | 1569 | 0.150 |
Why?
| | Enzyme Activation | 1 | 2020 | 785 | 0.150 |
Why?
| | Apoptosis | 4 | 2020 | 2363 | 0.150 |
Why?
| | Gene Silencing | 1 | 2018 | 171 | 0.150 |
Why?
| | Multigene Family | 1 | 2018 | 190 | 0.150 |
Why?
| | Cell Cycle | 1 | 2020 | 542 | 0.140 |
Why?
| | Celecoxib | 1 | 2016 | 38 | 0.140 |
Why?
| | Histones | 1 | 2021 | 535 | 0.140 |
Why?
| | Animals | 9 | 2021 | 31708 | 0.140 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 1 | 2016 | 55 | 0.130 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2017 | 59 | 0.130 |
Why?
| | Transcriptional Activation | 1 | 2018 | 337 | 0.130 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2016 | 96 | 0.130 |
Why?
| | Hematopoiesis | 1 | 2017 | 171 | 0.130 |
Why?
| | Gene Expression Profiling | 2 | 2020 | 1518 | 0.130 |
Why?
| | Humans | 14 | 2023 | 114698 | 0.130 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2016 | 172 | 0.130 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2021 | 534 | 0.120 |
Why?
| | Quantitative Structure-Activity Relationship | 1 | 2015 | 13 | 0.120 |
Why?
| | Nerve Tissue Proteins | 1 | 2018 | 529 | 0.120 |
Why?
| | beta Catenin | 1 | 2016 | 219 | 0.120 |
Why?
| | Fusion Proteins, bcr-abl | 3 | 2021 | 61 | 0.120 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2015 | 180 | 0.120 |
Why?
| | Cells, Cultured | 1 | 2022 | 3886 | 0.120 |
Why?
| | Cell Differentiation | 2 | 2021 | 1701 | 0.110 |
Why?
| | Disease Models, Animal | 2 | 2020 | 3535 | 0.110 |
Why?
| | Mutation | 2 | 2021 | 3346 | 0.100 |
Why?
| | Membrane Proteins | 1 | 2018 | 1019 | 0.100 |
Why?
| | Melanoma | 1 | 2018 | 620 | 0.100 |
Why?
| | Drug Resistance, Neoplasm | 3 | 2018 | 636 | 0.080 |
Why?
| | Prostatic Neoplasms | 1 | 2015 | 921 | 0.080 |
Why?
| | K562 Cells | 2 | 2018 | 73 | 0.070 |
Why?
| | Cell Lineage | 2 | 2021 | 309 | 0.070 |
Why?
| | Treatment Outcome | 1 | 2020 | 9088 | 0.070 |
Why?
| | Gene Expression | 2 | 2021 | 1421 | 0.050 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 1355 | 0.050 |
Why?
| | Disease Progression | 2 | 2018 | 2380 | 0.050 |
Why?
| | Leukemia, Myelomonocytic, Acute | 1 | 2021 | 7 | 0.050 |
Why?
| | Dexamethasone | 1 | 2023 | 317 | 0.050 |
Why?
| | Myeloid Cells | 1 | 2021 | 126 | 0.040 |
Why?
| | Signal Transduction | 3 | 2018 | 4515 | 0.040 |
Why?
| | Pyridines | 1 | 2023 | 425 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 591 | 0.040 |
Why?
| | Philadelphia Chromosome | 1 | 2018 | 15 | 0.040 |
Why?
| | Semaphorins | 1 | 2018 | 21 | 0.040 |
Why?
| | Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2018 | 22 | 0.040 |
Why?
| | Neoplasm Transplantation | 1 | 2018 | 228 | 0.040 |
Why?
| | Mice, SCID | 1 | 2018 | 314 | 0.040 |
Why?
| | GATA1 Transcription Factor | 1 | 2017 | 13 | 0.040 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 1 | 2017 | 15 | 0.040 |
Why?
| | Mice, Nude | 1 | 2018 | 630 | 0.030 |
Why?
| | Antigens, CD34 | 1 | 2017 | 89 | 0.030 |
Why?
| | Cyclooxygenase 2 Inhibitors | 1 | 2016 | 20 | 0.030 |
Why?
| | Imatinib Mesylate | 1 | 2016 | 63 | 0.030 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2016 | 60 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2018 | 555 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 84 | 0.030 |
Why?
| | Transfection | 1 | 2018 | 866 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2018 | 535 | 0.030 |
Why?
| | Drug Synergism | 1 | 2016 | 316 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2021 | 520 | 0.030 |
Why?
| | DNA Replication | 1 | 2017 | 202 | 0.030 |
Why?
| | Cell Line | 1 | 2021 | 2637 | 0.030 |
Why?
| | Cell Survival | 1 | 2018 | 1021 | 0.030 |
Why?
| | Tissue Culture Techniques | 1 | 2015 | 66 | 0.030 |
Why?
| | HeLa Cells | 1 | 2016 | 562 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2016 | 849 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2015 | 135 | 0.030 |
Why?
| | Small Molecule Libraries | 1 | 2015 | 79 | 0.030 |
Why?
| | Trans-Activators | 1 | 2017 | 367 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2015 | 257 | 0.030 |
Why?
| | Protein Multimerization | 1 | 2015 | 157 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2015 | 455 | 0.030 |
Why?
| | Proto-Oncogene Proteins | 1 | 2017 | 608 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2018 | 858 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 1842 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2021 | 4694 | 0.020 |
Why?
| | Cytokines | 1 | 2018 | 1841 | 0.020 |
Why?
| | Inflammation | 1 | 2021 | 2480 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 3329 | 0.020 |
Why?
| | Databases, Factual | 1 | 2015 | 1125 | 0.020 |
Why?
| | Models, Molecular | 1 | 2015 | 1369 | 0.020 |
Why?
| | Time Factors | 1 | 2016 | 6116 | 0.020 |
Why?
| | Adult | 1 | 2023 | 30553 | 0.010 |
Why?
| | Female | 1 | 2018 | 59520 | 0.010 |
Why?
| | Male | 1 | 2015 | 55606 | 0.010 |
Why?
|
|
De Dominici's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|